Equities research analysts expect Minerva Surgical, Inc. (NASDAQ:UTRS – Get Rating) to report ($0.34) earnings per share for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Minerva Surgical’s earnings, with the highest EPS estimate coming in at ($0.32) and the lowest estimate coming in at ($0.36). The company is […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Wall Street brokerages expect Minerva Surgical, Inc. (NASDAQ:UTRS – Get Rating) to announce earnings per share (EPS) of ($0.31) for the current quarter, Zacks reports. Three analysts have issued estimates for Minerva Surgical’s earnings, with the lowest EPS estimate coming in at ($0.32) and the highest estimate coming in at ($0.30). The firm is scheduled […]
Minerva Surgical (NASDAQ:UTRS – Get Rating) and Intersect ENT (NASDAQ:XENT – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk. Profitability This table compares Minerva Surgical and Intersect ENT’s […]
Wall Street brokerages expect that Minerva Surgical Inc (NASDAQ:UTRS – Get Rating) will report sales of $10.91 million for the current quarter, Zacks Investment Research reports. Three analysts have issued estimates for Minerva Surgical’s earnings, with estimates ranging from $10.22 million to $12.25 million. The firm is scheduled to report its next quarterly earnings report […]